What controls the expression of the core-1 (Thomsen - Friedenreich) glycotope on tumor cells?

Biochemistry (Moscow)

Volumn 80, Issue 7, 2015, Pages 801-807

  Karsten, U ^a   Goletz, S ^a  

^a GLYCOTOPE GMBH   (Germany)

Author keywords

core 1; glycolysis; glycosylation; Golgi; pH; Thomsen Friedenreich; tumor metabolism

Indexed keywords

THOMSEN-FRIEDENREICH ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

BIOSYNTHESIS; GENETICS; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM;

ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BIOMARKERS, TUMOR; GLYCOSYLATION; HUMANS; NEOPLASMS;

EID: 84937705709     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297915070019     Document Type: Review

References (64)

1. Friedenreich, V. (1930) The Thomsen Hemagglutination Phenomenon, Levin & Munksgaard, Copenhagen.
2. Kim, Z., and Uhlenbruck, G. (1966) Untersuchungen uber T-antigen und T-agglutinin, Z. Immun. Forsch., 130, 8899.
3. Springer, G. F., Desai, P. R., and Banatwala, I. (1975) Blood group MN antigens and precursors in normal and malignant human breast glandular tissue, J. Natl. Cancer Inst., 54, 335-339.
4. Springer, G. F. (1997) Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy, J. Mol. Med., 75, 594-602.
5. Springer, G. F. (1984) T and Tn, general carcinoma autoantigens, Science, 228, 1198-1206.
6. Cao, Y., Stosiek, P., Springer, G. F., and Karsten, U. (1996) Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study, Histochem. Cell Biol., 106, 197-207.
7. Cao, Y., Karsten, U., Liebrich, W., Haensch, W., Springer, G. F., and Schlag, P. M. (1995) Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation, Cancer, 76, 1700-1708.
8. Takanami, I. (1999) Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma, Oncol. Rep., 6, 341-344.
9. Baldus, S. E., Hanisch, F. G., Monaca, E., Karsten, U., Zirbes, T. K., Thiele, J., and Dienes, H. P. (1999) Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1, Histol. Histopathol., 14, 1153-1158.
10. Cao, Y., Karsten, U., Otto, G., and Bannasch, P. (1999) Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and a2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions, Virchows Arch., 434, 503-509.
11. Veerman, A. J. P., Hogeman, P. H. G., Huismans, D. R., Van Zantwijk, C. H., and Bezemer, P. D. (1985) Peanut agglutinin, a marker for T-cell acute lymphoblastic leukemia with a good prognosis, Cancer Res., 45, 1890-1893.
12. Karsten, U. (2002) CD176 workshop panel report, in Leucocyte Typing VII (Mason, D., ed.) Oxford University Press, Oxford, pp. 202-203.
13. Karsten, U., and Goletz, S. (2013) What makes cancer stem cell markers different? Springer Plus, 2, 301.
14. Brockhausen, I., Yang, J., Burchell, J., Whitehouse, C., and Taylor-Papadimitriou, J. (1995) Mechanism underlying aberrant glycosylation of the MUC1 mucin in breast cancer, Eur. J. Biochem., 233, 607-617.
15. Ermini, L., Bhattacharjee, J., Spagnoletti, A., Bechi, N., Aldi, S., Ferretti, C., Bianchi, L., Bini, L., Rosati, F., Paulesu, L., and Ietta, F. (2013) Oxygen governs Galß13GalNAc epitope in human placenta, Am. J. Physiol. Cell Physiol., 305, C931-C940.
16. Brockhausen, I. (1999) Pathways of O-glycan biosynthesis in cancer cells, Biochim. Biophys. Acta, 1473, 67-95.
17. Brockhausen, I. (2006) Mucin-type O-glycosylation in human colon and breast cancer: glycodynamics and functions, EMBO Rep., 7, 599-604.
18. Goletz, S., Cao, Y., Danielczyk, A., Ravn, P., Schoeber, U., and Karsten, U. (2003) Thomsen-Friedenreich antigen: the "hidden" tumor antigen, Adv. Exp. Med. Biol., 535, 147-162.
19. Burchell, J. M., Mungul, A., and Taylor-Papadimitriou, J. (2001) O-linked glycosylation in the mammary gland: changes that occur during malignancy, J. Mamm. Gland Biol. Neoplasm, 6, 355-364.
20. Vavasseur, F., Yang, J., Dole, K., Paulsen, H., and Brockhausen, I. (1995) Synthesis of core 3: characterization of UDP-GlcNAc: GalNAc ß3-N-acetylglucosaminyltransferase activity from colonic tissues. Loss of the activity in human cancer cell lines, Glycobiology, 5, 351-357.
21. Schneider, F., Kemmner, W., Haensch, W., Franke, G., Gretschel, S., Karsten, U., and Schlag, P. M. (2001) Overexpression of sialyltransferase CMP-sialic acid:Galß1,3GalNAc-R a6-sialyltransferase is related to poor patient survival in human colorectal carcinomas, Cancer Res., 61, 4605-4611.
22. Dalziel, M., Whitehouse, C., McFarlane, I., Brockhausen, I., Gschmeissner, S., Schwientek, T., Clausen, H., Burchell, J. M., and Taylor-Papadimitriou, J. (2001) The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1, J. Biol. Chem., 276, 11007-11015.
23. Gill, D. J., Tham, K. M., Chia, J., Wang, S. C., Steentoft, C., Clausen, H., Bard-Chapeau, E. A., and Bard, F. A. (2013) Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness, Proc. Natl. Acad. Sci. USA, 110, E3152-E3162.
24. Radhakrishnan, P., Dabelsteen, S., Madsen, F. B., Francavilla, C., Kopp, K. L., Steentoft, C., Vakhrushev, S. Y., Olsen, J. V., Hansen, L., Bennett, E. P., Woetmann, A., Yin, G., Chen, L., Song, H., Bak, M., Hlady, R. A., Peters, S. L., Opavsky, R., Thode, C., Qvortrup, K., Schjoldager, K. T. -B. G., Clausen, H., Hollingsworth, M. A., and Wandall, H. H. (2014) Immature truncated O-glycophenotype of cancer directly induces oncogenic features, Proc. Natl. Acad. Sci. USA, 111, E4066-E4075.
25. Ju, T., Otto, V. I., and Cummings, R. D. (2011) The Tn antigen-structural simplicity and biological complexity, Angew. Chem. Int. Ed., 50, 1770-1791.
26. Kumamoto, K., Goto, Y., Sekikawa, K., Takenoshita, S., Ishida, N., Kawakita, M., and Kannagi, R. (2001) Increased expression of UDP-galactose transporter RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants, Cancer Res., 61, 4620-4627.
27. Nilsson, T., Slusarewicz, P., Hoe, M. H., and Warren, G. (1993) Kin recognition. A model for the retention of Golgi enzymes, FEBS Lett., 330, 1-4.
28. De Graffenried, C. L., and Bertozzi, C. R. (2004) The roles of enzyme localization and complex formation of Golgi enzymes, Curr. Opin. Cell Biol., 16, 356-363.
29. Engelsberg, A., Hermosilla, R., Karsten, U., Schulein, R., Dorken, B., and Rehm, A. (2003) The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens, J. Biol. Chem., 278, 22998-23007.
30. Egea, G., Franci, C., Gambus, G., Lesuffleur, T., Zweibaum, A., and Real, F. X. (1993) Cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells, J. Cell Sci., 105, 819-830.
31. Sewell, R., Backstrom, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gatgens, J., Clausen, H., Hansson, G. C., Burchell, J., and Taylor-Papadimitriou, J. (2006) The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumorassociated sialyl-Tn-glycan in human breast cancer, J. Biol. Chem., 281, 3586-3594.
32. Rottger, S., White, J., Wandall, H. H., Olivo, J.-C., Stark, A., Bennett, E. P., Whitehouse, C., Berger, E. G., Clausen, H., and Nilsson, T. (1998) Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus, J. Cell Sci., 111, 45-60.
33. Axelsson, M. A. B., Karlsson, N. G., Steel, D. M., Ouwendijk, J., Nilsson, T., and Hansson, G. C. (2001) Neutralization of pH in the Golgi apparatus cause redistribution of glycosyltransferases and changes in the O-glycosylation of mucins, Glycobiology, 11, 633-644.
34. Campbell, B. J., Rowe, G. E., Leiper, K., and Rhodes, J. M. (2001) Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Galß1-3GalNaca-) expression seen in colon cancer, Glycobiology, 11, 385-393.
35. Thorens, B., and Vassalli, P. (1986) Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion, Nature, 321, 618-620.
36. Caplan, M. J., Stow, J. L., Newman, A. P., Madri, J., Anderson, H. C., Farquhar, M. G., Palade, G. E., and Jamieson, J. D. (1987) Dependence on pH of polarized sorting of secreted proteins, Nature, 329, 632-635.
37. Kellokumpu, S., Sormunen, R., and Kellokumpu, I. (2002) Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH, FEBS Lett., 516, 217-224.
38. Paroutis, P., Touret, N., and Grinstein, S. (2004) The pH of the secretory pathway: measurement, determinants, and regulation, Physiology, 19, 207-215.
39. Rivinoja, A., Kokkonen, N., Kellokumpu, I., and Kellokumpu, S. (2006) Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen, J. Cell. Physiol., 208, 167-174.
40. Gawlitzek, M., Ryll, T., Lofgren, J., and Sliwkowski, M. B. (2000) Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms, Biotechnol. Bioeng., 68, 637-646.
41. Rivinoja, A., Hassinen, A., Kokkonen, N., Kauppila, A., and Kellokumpu, S. (2009) Elevated Golgi pH impairs terminal N-glycosylation by inducing mislocalization of Golgi glycosyltransferases, J. Cell. Physiol., 220, 144-154.
42. Hassinen, A., Pujol, F. M., Kokkonen, N., Pieters, C., Kihlstrom, M., Korhonen, K., and Kellokumpu, S. (2011) Functional organization of the Golgi Nand O-glycosylation pathways involves pH-dependent complex formation that is impaired in cancer cells, J. Biol. Chem., 286, 38329-38340.
43. Hassinen, A., and Kellokumpu, S. (2014) Organizational interplay of Golgi N-glycosyltransferases involves organelle microenvironment-dependent transitions between enzyme homoand heteromers, J. Biol. Chem., 289, 26937-26948.
44. Rivinoja, A., Pujol, F. M., Hassinen, A., and Kellokumpu, S. (2012) Golgi pH, its regulation and roles in human disease, Ann. Med., 44, 542-554.
45. Maeda, Y., Ide, T., Koike, M., Uchiyama, Y., and Kinoshita, T. (2008) GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus, Nature Cell Biol., 10, 1135-1145.
46. Marshansky, V., Rubinstein, J. L., and Gruber, G. (2014) Eukaryotic V-ATPase: novel structural findings and functional insights, Biochim. Biophys. Acta, 1837, 857-879.
47. Warburg, O., Wind, F., and Negelein, E. (1927) The metabolism of tumors in the body, J. Gen. Physiol., 8, 519-530.
48. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation, Cell, 144, 646-674.
49. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab., 7, 11-20.
50. Gillies, R. J., Raghunand, N., Karczmar, G. S., and Bhujwalla, Z. M. (2002) MRI of the tumor microenvironment, J. Magn. Reson. Imag., 16, 430-450.
51. Damaghi, M., Wojtkowiak, J. W., and Gillies, R. J. (2013) pH sensing and regulation in cancer, Front. Physiol., 4; http://dx.doi.org/10.3389/fphys.2013.00370.
52. Gatenby, R. A., Smallbone, K., Maini, P. K., Rose, F., Averill, J., Nagle, R. B., Worrall, L., and Gillies, R. J. (2007) Cellular adaptions to hypoxia and acidosis during somatic evolution of breast cancer, Brit. J. Cancer, 97, 646-653.
53. Vogelstein, B., and Kinzler, K. W. (2004) Cancer genes and the pathways they control, Nature Med., 10, 789-799.
54. Kroemer, G., and Pouyssegur, J. (2008) Tumor cell metabolism: cancer's Achilles heel, Cancer Cell, 13, 472-482.
55. Cardone, R. A., Casavola, V., and Reshkin, S. J. (2005) The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis, Nature Rev. Cancer, 5, 786-795.
56. Wong, N., De Melo, J., and Tang, D. (2013) PKM2, a central point of regulation in cancer metabolism, Int. J. Cell Biol.; http://dx.doi.org/10.1155/2013/242513.
57. Semenza, G. L. (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations, J. Clin. Invest., 123, 3665-3671.
58. Soonthornsit, J., Yamaguchi, Y., Tamura, D., Ishida, R., Nakakoji, Y., Osako, S., Yamamoto, A., and Nakamura, N. (2014) Low cytoplasmic pH reduces ER-Golgi trafficking and induces disassembly of the Golgi apparatus, Exp. Cell Res., 328, 325-339.
59. Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., Pandolfi, P. P., and Haigis, M. C. (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIFa destabilization, Cancer Cell, 19, 416-428.
60. Schapiro, F., Sparkowski, J., Adduci, A., Suprynowicz, F., Schlegel, R., and Grinstein, S. (2000) Golgi alkalinization by the papillomavirus E5 oncoprotein, J. Cell Biol., 148, 305-315.
61. Sautin, Y. Y., Lu, M., Gaugler, A., Zhang, L., and Gluck, S. L. (2005) Phosphatidylinositol 3-kianse-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells, Mol. Cell. Biol., 25, 575-589.
62. Jeschke, U., Richter, D. U., Hammer, A., Briese, V., Friese, K., and Karsten, U. (2002) Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro, Histochem. Cell Biol., 117, 219-226.
63. Ito, K., and Suda, T. (2014) Metabolic requirements for the maintenance of self-renewing stem cells, Nature Rev. Mol. Cell Biol., 15, 243-256.
64. Martinez-Outschoorn, U. E., Lisanti, M. P., and Sotgia, F. (2014) Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth, Seminars Cancer Biol., 25, 47-60.